(Q50986471)

26 March 2018

title

Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia. (English)

1 reference

26 March 2018

0 references

1 reference

Avram MM

1

1 reference

26 March 2018

Sreedhara R

2

1 reference

26 March 2018

Avram DK

3

1 reference

26 March 2018

Muchnick RA

4

1 reference

26 March 2018

Fein P

5

1 reference

26 March 2018

publication date

1 December 1996

1 reference

26 March 2018

American Journal of Kidney Diseases

published in

1 reference

26 March 2018

volume

28

1 reference

26 March 2018

issue

6

1 reference

26 March 2018

page(s)

924-930

1 reference

26 March 2018

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Effect of nutrition on morbidity and mortality in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Canadian Hemodialysis Morbidity Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Markers for survival in dialysis: a seven-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Soft tissue calcification in pediatric patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Clinical review 20: Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Phosphorus and protein restriction and parathyroid function in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Phosphate restriction reduces proteinuria of the uninephrectomized, diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Preservation of function in experimental renal disease by dietary restriction of phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Is parathyroid hormone a uremic toxin?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Neurodiagnostic abnormalities in patients with acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Insulin secretion and growth failure in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

The role of the parathyroid glands in the uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Acute effects of increased meat protein on urinary electrolytes and cyclic adenosine monophosphate and serum parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Why are dialysis patients malnourished?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Amino acid and albumin losses during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. The National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990396-0

7 January 2021

10.1016/S0272-6386(96)90396-0

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

8957048

1 reference

26 March 2018